Tumor size as a prognostic factor in resected small hepatocellular carcinoma: A controversy revisited

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 5, 2011, Pages 851-857

  Chen, Yao Li ^a,b   Ko, Chih Jan ^a   Chien, Su Yu ^a   Chen, Li Sheng ^c   Chen, Mei Ling ^a   Chi, Chin Wen ^d   Lai, Hung Wen ^a,d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Hepatitis; Hepatocellular carcinoma; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR VOLUME;

EID: 79954452301     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06595.x     Document Type: Article

References (24)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001; 2: 533-43.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
3. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 2003; 139: 817-23.
4. Jan CF, Chen CJ, Chen HH. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience. J. Gastroenterol. Hepatol. 2005; 20: 521-6.
5. Department of Health, The Executive Yuan, Republic of China. Cancer Registry Annual Report Republic of China. 2005. Department of Health, The Executive Yuan, Republic of China, 2008.
6. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987; 47: 4967-72.
7. Deuffic S, Poynard T, Valleron AJ. Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J. Viral Hepat. 1999; 6: 411-13.
8. Chen TH, Chen CJ, Yen MF etal. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int. J. Cancer 2002; 98: 257-61.
9. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2004; 130: 417-22.
10. Chen TH, Chiu YH, Luh DL etal. Community-based multiple screening model: design, implementation, and analysis of 42387 participants. Cancer 2004; 100: 1734-43.
11. Yamamoto M, Takasaki K, Otsubo T etal. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann. Surg. 2004; 239: 395-9.
12. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13772 patients in Japan. Ann. Surg. 2007; 245: 909-22.
13. Nathan H, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of early hepatocellular carcinoma. Ann. Surg. 2009; 249: 799-805.
14. Cescon M, Cucchetti A, Grazi GL etal. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch. Surg. 2009; 144: 906-13.
15. Tsai TJ, Chau GY, Lui WY etal. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-8.
16. Pawlik TM, Delman KA, Vauthey JN etal. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005; 11: 1086-92.
17. Vauthey JN, Lauwers GY, Esnaola NF etal. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 2002; 20: 1527-36.
18. Greene FL, American Joint Committee on Cancer; American Cancer Society. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002.
19. Edge SB, Byrd DR, Carducci M, Compton CC, Fritz AG. AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2009.
20. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
21. Okuda K, Ohtsuki T, Obata H etal. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
22. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840-5.
23. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999; 19: 329-38.
24. Fleming ID, American Joint Committee on Cancer; American Cancer Society; American College of Surgeons. AJCC Cancer Staging Manual, 5th edn. Philadelphia, PA: Lippincott-Raven, 1997.